Undervalued Dividend Growth Stock of the Week: Merck (MRK)
It’s set up for a golden era and in many ways, never looked better.
Read MorePosted by Jason Fieber, Dividends and Income | Dec 20, 2024
It’s set up for a golden era and in many ways, never looked better.
Read MorePosted by Jason Fieber, Dividends and Income | Dec 13, 2024
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 28% undervalued, dividend growth investors in the market for deep value and high yield have a very interesting opportunity on their hands with this one.
Read MorePosted by Jason Fieber, Dividends and Income | Dec 6, 2024
With a market-smashing yield, more than 25 consecutive years of dividend increases, and the potential that shares are 16% undervalued, value-seeking dividend growth investors willing to take a swing on a beaten-up stock have a fat pitch coming right down the plate here.
Read MorePosted by Jason Fieber, Dividends and Income | Nov 29, 2024
With a market-like yield, more than 30 consecutive years of dividend increases and the potential that shares are 4% undervalued, this could be a unique opportunity to invest in a terrific business at a better-than-fair price.
Read MorePosted by Jason Fieber, Dividends and Income | Nov 22, 2024
With a market-beating yield, a double-digit long-term dividend growth rate, and the potential that shares are 21% undervalued, this appears to be the cheapest way to play US defense in a world where geopolitical tensions are showing no signs of abating.
Read More
